Associate Director, Ophthalmic Clinical Pharmacology

Bausch + Lomb; Montgomery (AL); On-site; USD 130,000 - 200,000; Full time

Benefits offered by this job

Medical, dental, vision insurance

401(k) plan with company match

Tuition reimbursement

Paid holidays and well-being benefits

Job summary

Bausch + Lomb in the United States seeks a translational scientist to lead clinical pharmacology and pharmacometrics activities across Rx ophthalmic and consumer eye health programs. The role requires a PhD and 6+ years' experience in PK/PD, PBPK, and modeling, with leadership in project delivery and cross-functional collaboration.

You will design studies, support regulatory filings, and communicate findings to management and external partners while staying current with ICH/FDA guidance.

Qualifications

• PhD in Pharmaceutical Sciences, Clinical Pharmacology, Pharmacometrics, or related field.
• 6+ years of relevant experience in PK/PD, pharmacometrics, or systems pharmacology.
• Ophthalmic drug development or ocular PK experience strongly preferred.

Responsibilities

• Lead clinical pharmacology, PK/PD and pharmacometrics activities across Rx ophthalmic programs.
• Design and oversee nonclinical PK and clinical pharmacology studies including first-in-human.
• Communicate implications to management and support regulatory submissions.
• Maintain up-to-date knowledge of PK/PD methods and software.

Skills

Leadership PK/PD

Regulatory collaboration

Communication

Vendor management

Education

PhD in Pharmaceutical Sciences

Tools

NONMEM

Monolix

Phoenix WinNonlin

R

GastroPlus

MATLAB

Job description

Bausch + Lomb in the United States seeks a translational scientist to lead clinical pharmacology and pharmacometrics activities across Rx ophthalmic and consumer eye health programs. The role requires a PhD and 6+ years' experience in PK/PD, PBPK, and modeling, with leadership in project delivery and cross-functional collaboration.

You will design studies, support regulatory filings, and communicate findings to management and external partners while staying current with ICH/FDA guidance.